Identification of a high-risk subgroup of patients with resected pT3 oral cavity cancer in need of postoperative adjuvant therapy

Annals of Surgical Oncology

Volumn 18, Issue 9, 2011, Pages 2569-2578

  Liao, Chun Ta ^a   Lin, Chien Yu ^a   Fan, Kang Hsing ^a   Huang, Shiang Fu ^a   Chen, I How ^a   Kang, Chung Jan ^a   Wang, Hung Ming ^a   Ng, Shu Hang ^a   Hsueh, Chuen ^a   Lee, Li Yu ^a   Lin, Chih Hung ^a   Yen, Tzu Chen ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PROGNOSIS; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE PERIOD; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 80052751498     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1616-4     Document Type: Article

References (18)

1. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM. AJCC cancer staging manual. 7th ed. New York: Springer-Verlag; 2010.
2. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology, Head and Neck Cancers, V. I. 2010. http://www.nccn.org/. Accessed 21 May 2010.
3. JP Shah Z Gil 2009 Current concepts in management of oral cancer-surgery Oral Oncol 45 394 401 18674952 10.1016/j.oraloncology.2008.05.017
4. A Ballonoff C Chen D Raben 2006 Current radiation therapy management issues in oral cavity cancer Otolaryngol Clin North Am 39 365 380 16580917 10.1016/j.otc.2005.11.004
5. JA Langendijk MA de Jong CR Leemans R de Bree LE Smeele P Doornaert, et al. 2003 Postoperative radiotherapy in squamous cell carcinoma of the oral cavity: the importance of the overall treatment time Int J Radiat Oncol Biol Phys 57 693 700 14529773 10.1016/S0360-3016(03)00624-2 1:STN:280: DC%2BD3svmvVaitw%3D%3D (Pubitemid 37194295)
6. DI Rosenthal L Liu JH Lee N Vapiwala AA Chalian GS Weinstein, et al. 2002 Importance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neck Head Neck 24 115 126 11891941 10.1002/hed.10038 (Pubitemid 34111508)
7. CT Liao JT Chang HM Wang SH Ng C Hsueh LY Lee, et al. 2007 Survival in squamous cell carcinoma of the oral cavity: differences between pT4N0 and other stage IVA categories Cancer. 110 564 571 17577219 10.1002/cncr.22814 (Pubitemid 47106145)
8. CT Liao JT Chang HM Wang SH Ng C Hsueh LY Lee, et al. 2008 Does adjuvant radiation therapy improve outcome in pT1-3N0 oral cavity cancer with tumor-free margins and peripheral invasion? Int J Radiat Oncol Biol Phys 71 371 376 18474310 10.1016/j.ijrobp.2007.10.015 (Pubitemid 351636193)
9. CT Liao JT Chang HM Wang SH Ng C Hsueh LY Lee, et al. 2008 Analysis of risk factors predictive of local tumor control in oral cavity cancer Ann Surg Oncol 15 915 922 18165878 10.1245/s10434-007-9761-5
10. JS Brown TK Blackburn JA Woolgar D Lowe RD Errington ED Vaughan, et al. 2007 A comparison of outcomes for patients with oral squamous cell carcinoma at intermediate risk of recurrence treated by surgery alone or with post-operative radiotherapy Oral Oncol 43 764 773 17174140 10.1016/j.oraloncology.2006.09.010 1:STN:280:DC%2BD2svovVeguw%3D%3D (Pubitemid 47259442)
11. J Bernier C Domenge M Ozsahin K Matuszewska JL Lefèbvre RH Greiner, et al. 2004 Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer N Engl J Med 350 1945 1952 15128894 10.1056/NEJMoa032641 1:CAS:528:DC%2BD2cXjslehsrk%3D (Pubitemid 38580197)
12. JS Cooper TF Pajak AA Forastiere J Jacobs BH Campbell SB Saxman, et al. 2004 Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck N Engl J Med 350 1937 1944 15128893 10.1056/NEJMoa032646 (Pubitemid 38580196)
13. J Bernier JS Cooper TF Pajak M van Glabbeke J Bourhis A Forastiere, et al. 2005 Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501) Head Neck 27 843 850 16161069 10.1002/hed.20279 (Pubitemid 41395696)
14. J Bernier JB Vermorken WM Koch 2006 Adjuvant therapy in patients with resected poor-risk head and neck cancer J Clin Oncol 24 2629 2635 16763276 10.1200/JCO.2005.05.0906 (Pubitemid 46622084)
15. JA Brennan L Mao RH Hruban JO Boyle YJ Eby WM Koch, et al. 1995 Molecular assessment of histopathologic staging in squamous-cell carcinoma of the head and neck N Engl J Med 332 429 435 7619114 10.1056/NEJM199502163320704 1:STN:280:DyaK2M7isVCgsA%3D%3D
16. CO Nathan N Amirghahari F Abreo X Rong G Caldito ML Jones, et al. 2004 Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway Clin Cancer Res 17 5820 5824 10.1158/1078-0432.CCR-03-0483 (Pubitemid 39180961)
17. M Baghi M Hambek A May A Radeloff W Gstoettner R Knecht 2006 Adjuvant docetaxel, cisplatin and 5-fluorouracil (TPF) in locally advanced squamous cell carcinoma of the head and neck Anticancer Res 26 559 563 16739320 1:CAS:528:DC%2BD28Xhs1ahsrk%3D (Pubitemid 43206016)
18. DI Rosenthal J Harris AA Forastiere RS Weber JA Ridge JN Myers, et al. 2009 Early postoperative paclitaxel followed by concurrent paclitaxel and cisplatin with radiation therapy for patients with resected high-risk head and neck squamous cell carcinoma: report of the phase II trial RTOG 0024 J Clin Oncol 27 4727 4732 19720915 10.1200/JCO.2008.21.4197 1:CAS:528: DC%2BD1MXhtlGgtbnF